# Sativa Wellness Group research paper on effects of cannabinoids on lung inflammation now published

- Link: https://www.directorstalkinterviews.com/sativa-wellness-group-research-paper-on-effects-of-cannabinoids-on-lung-inflammation-now-published/412998927
- Published: 2021-06-09T07:37:46+01:00
- Author: Giles

**Sativa Wellness Group Inc** ([AQSE:SWEL](https://www.directorstalkinterviews.com/company/goodbody-health/gdby.cn))
has announced that following its collaboration with King’s College London, investigating
the potential therapeutic use of cannabinoids for the treatment of respiratory diseases,
a research paper including the results of part of this research has been published.

The primary purpose of this study was to investigate the anti-inflammatory effects
of two of the non-psychotropic cannabinoids, cannabidiol (CBD) and cannabigerol (
CBG) alone and in combination, in a model of pulmonary inflammation. The results
of the work suggest that the cannabinoids CBD and CBG in combination have significant
anti-inflammatory activity in the lung.   

The work undertaken builds on previous research that suggests cannabinoids are promising
potential treatments for inflammatory diseases. Another important part of the research
identified that the formulation for administering cannabinoids is critically important
to obtain efficacy and highlights the importance of choosing an appropriate formulation
to obtain optimal benefit from administering cannabinoids.

> **Geremy Thomas, Sativa Wellness Group Executive Chairman, says; **“We have actively
> supported research now for over 2 years to identify the therapeutic benefits cannabinoids
> can have on medical conditions. Research is something we as a company believe 
> is essential to inform the public and we are delighted to have seen such positive
> results identified. Sativa Group will continue to invest in scientific research
> to ensure that the cannabinoid products it develops under ‘Goodbody Botanicals’
> and ‘Goodbody Store’, deliver the appropriate benefits” 

The full research paper can be found at: https://www.sciencedirect.com/science/article/
abs/pii/S1094553921000596

**Background**

On 2 April 2019, Sativa Investments PLC announced that it had entered into a research
agreement with King’s College London (“the College”) to research the impact of cannabinoids
on inflammation and respiratory diseases. Sativa Wellness sponsored the study as
part of the research agreement with the College.

Share on:
